Condensed Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-In-Capital	Additional Paid-In-Capital Cumulative Effect, Period of Adoption, Adjustment	Treasury Stock	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2020	$ 2,249,695	$ (49,530)	$ 10	$ 799,549	$ (55,590)	$ (74,124)	$ 1,524,878	$ 6,060	$ (618)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	4,254			4,254
Repurchase of common stock	(1,307)					(1,307)
Changes in comprehensive income	52								52
Issuance of warrants	2,146			2,146
Net income (loss)	(112,321)						(112,321)
Ending balance at Mar. 31, 2021	2,092,989		10	750,359		(75,431)	1,418,617		(566)
Beginning balance at Dec. 31, 2020	2,249,695	$ (49,530)	10	799,549	$ (55,590)	(74,124)	1,524,878	$ 6,060	(618)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(385,410)
Ending balance at Sep. 30, 2021	2,198,824		11	1,129,263		(75,476)	1,145,528		(502)
Beginning balance at Mar. 31, 2021	2,092,989		10	750,359		(75,431)	1,418,617		(566)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock and warrants, net	373,187		1	373,186
Share-based compensation	2,486			2,486
Repurchase of common stock	(17)					(17)
Changes in comprehensive income	25								25
Net income (loss)	(287,863)						(287,863)
Ending balance at Jun. 30, 2021	2,180,807		11	1,126,031		(75,448)	1,130,754		(541)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	3,232			3,232
Repurchase of common stock	(28)					(28)
Changes in comprehensive income	39								39
Net income (loss)	14,774						14,774
Ending balance at Sep. 30, 2021	2,198,824		11	1,129,263		(75,476)	1,145,528		(502)
Beginning balance at Dec. 31, 2021	2,114,035		11	1,131,826		(75,639)	1,058,369		(532)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	4,046			4,046
Repurchase of common stock	(1,772)					(1,772)
Changes in comprehensive income	(230)								(230)
Net income (loss)	(194,703)						(194,703)
Ending balance at Mar. 31, 2022	1,921,376		11	1,135,872		(77,411)	863,666		(762)
Beginning balance at Dec. 31, 2021	2,114,035		11	1,131,826		(75,639)	1,058,369		(532)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(283,486)
Ending balance at Sep. 30, 2022	1,839,777		11	1,143,076		(77,446)	774,883		(747)
Beginning balance at Mar. 31, 2022	1,921,376		11	1,135,872		(77,411)	863,666		(762)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Convertible debt conversions	2,705		0	2,705
Share-based compensation	1,677			1,677
Repurchase of common stock	(5)					(5)
Changes in comprehensive income	(132)								(132)
Net income (loss)	(52,406)						(52,406)
Ending balance at Jun. 30, 2022	1,873,215		11	1,140,254		(77,416)	811,260		(894)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	2,822			2,822
Repurchase of common stock	(30)					(30)
Changes in comprehensive income	147								147
Net income (loss)	(36,377)						(36,377)
Ending balance at Sep. 30, 2022	$ 1,839,777		$ 11	$ 1,143,076		$ (77,446)	$ 774,883		$ (747)